RAPT
RAPT Therapeutics, Inc.Company Information
- Company Name
- RAPT Therapeutics, Inc.
- CIK
- CIK0001673772
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- RAPT: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- RAPT
SEC filing data through
Insider Sentiment
- Last purchase
- 2023-03-14
- Last sale
- 2024-01-05
- Shares purchased (TTM)
- 2,500
- Shares sold (TTM)
- 30,640
Institutional Sentiment
- As of
- 2025-12-31
- Institutional shares owned
- 27,167,153
- Shares outstanding
- 26,963,107
- Ownership
- 100.76%
Earnings Market Reaction
- Filing date
- 2025-11-06
- Price on filing date
- —
- 1-month reaction
- 16.39%
- 3-month reaction
- 98.45%
Balance Sheet
Values in millions ($)| Line item | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 38 | 42 | 60 | 170 | 38 | 37 | 45 | 47 | 54 | 50 | 46 | 39 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 161 | 173 | 183 | 235 | 103 | 120 | 148 | 162 | 187 | 207 | 235 | 253 | ||||||
| Marketable Securities Current | 119 | 127 | 119 | 61 | 60 | 78 | 96 | 111 | 131 | 155 | 186 | 210 | ||||||
| Prepaid Expense And Other Assets Current | 4 | 4 | 4 | 4 | 5 | 6 | 7 | 3 | 2 | 2 | 3 | 4 | ||||||
| Property Plant And Equipment Net | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | ||||||
| Operating Lease Right Of Use Asset | 2 | 2 | 3 | 3 | 4 | 4 | 5 | 5 | 6 | 6 | 7 | 7 | ||||||
| Other Assets Noncurrent | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 4 | 4 | 4 | 4 | 4 | ||||||
| Assets | 166 | 178 | 188 | 240 | 108 | 127 | 156 | 173 | 200 | 221 | 248 | 266 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable Current | 2 | 4 | 1 | 1 | 1 | 3 | 7 | 5 | 5 | 3 | 9 | 3 | ||||||
| Accrued Liabilities Current | 9 | 7 | 5 | 10 | 6 | 9 | 12 | 14 | 14 | 10 | 10 | 9 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 13 | 13 | 9 | 48 | 10 | 15 | 21 | 22 | 22 | 15 | 22 | 14 | ||||||
| Operating Lease Liability Current | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | ||||||
| Other Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | 0 | 1 | 2 | 2 | 3 | 3 | 4 | 4 | 5 | 6 | 6 | 7 | ||||||
| Liabilities | 14 | 14 | 10 | 50 | 13 | 18 | 25 | 26 | 27 | 21 | 28 | 21 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 819 | 814 | 809 | 804 | 657 | 652 | 646 | 632 | 627 | 622 | 617 | 613 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | 152 | 164 | 177 | 190 | 96 | 109 | 131 | 147 | 173 | 200 | 220 | 245 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 | -0 | -0 | 0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -667 | -649 | -632 | -615 | -561 | -543 | -515 | -485 | -454 | -422 | -397 | -368 | ||||||
| Liabilities And Stockholders Equity | 166 | 178 | 188 | 240 | 108 | 127 | 156 | 173 | 200 | 221 | 248 | 266 | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | - | - | 0.00 | - | - | - | 0.00 | - | - | - | 0.00 | ||||||
| Preferred Stock Shares Authorized | - | - | - | 50 | - | - | - | 50 | - | - | - | 50 | ||||||
| Preferred Stock Shares Issued | - | - | - | 0 | - | - | - | 0 | - | - | - | 0 | ||||||
| Preferred Stock Shares Outstanding | - | - | - | 0 | - | - | - | 0 | - | - | - | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | - | - | - | 0.00 | - | - | - | 0.00 | - | - | - | 0.00 | ||||||
| Common Stock Shares Authorized | - | - | - | 500 | - | - | - | 500 | - | - | - | 500 | ||||||
| Common Stock Shares Issued | - | - | - | 132 | - | - | - | 34 | - | - | - | 4 | ||||||
| Shares Outstanding | - | - | - | 132 | - | - | - | 34 | - | - | - | 4 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialRAPT Therapeutics, Inc. (RAPT) — SEC Financial Statements & Analysis
RAPT Therapeutics, Inc. (RAPT) is a pharmaceutical preparations company, incorporated in DE. RAPT Therapeutics, Inc. trades on Nasdaq as: RAPT. RAPT Therapeutics, Inc. (RAPT)'s most recent SEC filing is a Form 10-Q for the period ended 2025-09-30, filed with the SEC on 2025-11-06. Based on that filing, On profitability, RAPT Therapeutics, Inc. posts an operating margin of -10900.68%, a net margin of -10456.09%, a Return on Equity (ROE) of -85.37%, a Return on Assets (ROA) of -77.05%, and a Return on Invested Capital (ROIC) of -131.24%. Per share, it reports EPS of $-3.92, diluted EPS of $-3.92, free cash flow per share of $-3.21, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of -1.73% year-over-year, and EPS growth of -82.28% year-over-year. On the balance sheet, it maintains a current ratio of 12.04x, a quick ratio of 11.76x, working capital of $147.67M, a debt-to-equity ratio of 0.09x, a debt ratio of 0.08, free cash flow of $-86.66M (TTM), and net debt of $-37.93M. Figures sourced from SEC EDGAR.
- EPS TTM
- $-3.92
- ROE TTM
- -85.37%
- ROA TTM
- -77.05%
- Debt To Equity
- 0.09x
- Free Cash Flow TTM
- $-86.66M
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2025-09-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is RAPT Therapeutics, Inc. in?
RAPT Therapeutics, Inc. (RAPT) operates in the Pharmaceutical Preparations industry.
What exchange does RAPT trade on?
RAPT Therapeutics, Inc. (RAPT) trades on the Nasdaq.
Where is RAPT Therapeutics, Inc. incorporated?
RAPT Therapeutics, Inc. is incorporated in DE.
When was RAPT Therapeutics, Inc. (RAPT)'s most recent SEC filing?
RAPT Therapeutics, Inc. (RAPT)'s most recent SEC filing is a Form 10-Q for the period ended 2025-09-30, filed with the SEC on 2025-11-06.
What is RAPT's EPS (earnings per share)?
RAPT Therapeutics, Inc. (RAPT)'s trailing twelve month EPS is $-3.92 as of 2025-09-30.
What is RAPT's ROE (return on equity)?
RAPT Therapeutics, Inc. (RAPT)'s trailing twelve month Return on Equity (ROE) is -85.37% as of 2025-09-30.
What is RAPT's ROA (return on assets)?
RAPT Therapeutics, Inc. (RAPT)'s trailing twelve month Return on Assets (ROA) is -77.05% as of 2025-09-30.
What is RAPT's ROIC (return on invested capital)?
RAPT Therapeutics, Inc. (RAPT)'s trailing twelve month Return on Invested Capital (ROIC) is -131.24% as of 2025-09-30.